Your browser doesn't support javascript.
loading
A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrhea.
Rahbek, Martin Torp; Lund, Lars Christian; Hallas, Jesper.
Affiliation
  • Rahbek MT; Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
  • Lund LC; Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
  • Hallas J; Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
Pharmacoepidemiol Drug Saf ; 33(1): e5673, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37559355
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Hypoglycemic Agents Type of study: Clinical_trials / Diagnostic_studies / Screening_studies Limits: Humans / Middle aged Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: Denmark Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Hypoglycemic Agents Type of study: Clinical_trials / Diagnostic_studies / Screening_studies Limits: Humans / Middle aged Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: Denmark Country of publication: United kingdom